Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
NATIONAL HEALTH INVESTORS INC
Bear Case (25th pct.)
-52.2% vs price
Base Case (Median)
-36.1% vs price
Bull Case (75th pct.)
-23.4% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $53.01 | -19.3% | Medium (25%) |
| Growth Trajectory DCF | $22.01 | -66.5% | Medium (20%) |
| Graham Number | $49.45 | -24.8% | Low (10%) |
| EV/EBITDA | $34.56 | -47.4% | Medium (20%) |
Based on 4 out of 7 methods, NHI appears overvalued at the current price of $65.72. The base case fair value of $42.01 implies 36.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.